Wk Of Use Research Articles

Elevated vacuum suspension preserves residual-limb skin health in people with lower-limb amputation: Randomized clinical trial.

ClinicalTrials.gov; "Evaluation of limb health associated with a prosthetic vacuum socket system": NCT01839123; https://clinicaltrials.gov/ct2/show/NCT01839123?term=NCT01839123&rank=1.

Evaluation of Nonlinear Frequency Compression for School-Age Children with Moderate to Moderately Severe Hearing Loss

Previous research has indicated that children with moderate hearing loss experience difficulty with recognition of high-frequency speech sounds, such as fricatives and affricates. Conventional behind-the-ear (BTE) amplification typically does not provide ample output in the high frequencies (4000 Hz and beyond) to ensure optimal audibility for these sounds. To evaluate nonlinear frequency compression (NLFC) as a means to improve speech recognition for children with moderate to moderately severe hearing loss. Within subject, crossover design with repeated measures across test conditions. Fifteen children, aged 5-13 yr, with moderate to moderately severe high-frequency sensorineural hearing loss were fitted with Phonak Nios, microsized, BTE hearing aids. These children were previous users of digital hearing aids and communicated via spoken language. Their speech and language abilities were age-appropriate. Aided thresholds and speech recognition in quiet and in noise were assessed after 6 wk of use with NLFC and 6 wk of use without NLFC. Participants were randomly assigned to counter-balanced groups so that eight participants began the first 6 wk trial with NLFC enabled and the other seven participants started with NLFC disabled. Then, the provision of NLFC was switched for the second 6 wk trial. Speech recognition in quiet was assessed via word recognition assessments with the University of Western Ontario (UWO) Plural Test and recognition of vowel-consonant-vowel nonsense syllables with the Phonak Logatome test. Speech recognition in noise was assessed by evaluating the signal-to-noise ratio in dB for 50% correct performance on the Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) test, an adaptive test of speech perception in a multitalker babble background. Aided thresholds for high-frequency stimuli were significantly better when NLFC was enabled, and use of NLFC resulted in significantly better speech recognition in quiet for the UWO Plural Test and for the phonemes /d/ and /s/ on the Phonak Logatome test. There was not a statistically significant difference in performance on the BKB-SIN test between the NLFC enabled and disabled conditions. These results indicate that NLFC improves audibility for and recognition of high-frequency speech sounds for children with moderate to moderately severe hearing loss in quiet listening situations.

Plaque formation and lactic acid production after the use of amine fluoride/stannous fluoride mouthrinse

The aim of this study was to determine the effects of 3 wk of daily rinsing with amine fluoride/stannous fluoride (AmF/SnF(2)) mouthrinse on plaque formation at buccal and interproximal sites, and on the acid production in plaque, in a randomized clinical trial with 30 participants. The amount of plaque was scored according to Turesky's modification of the Quigley and Hein index. Plaque samples were collected, before and after sucrose rinsing, from the buccal and interproximal surfaces of upper (pre)molars at two baseline visits and on days 2 and 7 after the discontinuation of 3 wk of daily rinsing. Metabolic acid ions were determined by capillary electrophoresis. The results at baseline showed higher lactic acid concentrations in resting interproximal plaque than in buccal plaque, and a higher acid production in response to sucrose challenge in buccal plaque than in interproximal plaque. After 3 wk of use of the AmF/SnF(2) mouthrinse, no significant differences in plaque scores were observed, and the alleged reduction in acidogenicity of dental plaque was not significant on the second day after the last mouthrinse. We conclude that 3 wk of use of AmF/SnF(2) rinse once daily does not result in a reduction of plaque formation or in a reduction of sucrose metabolism in buccal and interproximal plaque after discontinuing the rinse.

Topical Capsaicin in Painful Diabetic Neuropathy

Objective –To examine the effect of capsaicin on sensory function in painful diabetic neuropathy. Research Design and Methods –We examined the effects of topical 0.075% capsaicin cream on thermal and vibration thresholds in 22 subjects with painful diabetic neuropathy who participated in a double-blind vehicle-controlled therapeutic trial. Results –After 8 wk of use, there was no significant change in warm and vibration thresholds, but the cold threshold was significantly reduced by capsaicin and vehicle creams to an equal degree. In fewer subjects who used capsaicin cream in an open-label study, there was no significant effect on sensory thresholds after up to 32 wk of use. Conclusions –Although our results and those of others show no adverse effects of topical 0.075% capsaicin on human sensory function, even in subjects with preexisting neuropathic sensory impairment, the small number of subjects tested does not justify an inferential statement on safety. Further studies in more subjects are warranted to ensure the long-term safety of capsaicin for pain relief in humans.

Topical Capsaicin in Painful Diabetic Neuropathy: Effect on Sensory Function

To examine the effect of capsaicin on sensory function in painful diabetic neuropathy. We examined the effects of topical 0.075% capsaicin cream on thermal and vibration thresholds in 22 subjects with painful diabetic neuropathy who participated in a double-blind vehicle-controlled therapeutic trial. After 8 wk of use, there was no significant change in warm and vibration thresholds, but the cold threshold was significantly reduced by capsaicin and vehicle creams to an equal degree. In fewer subjects who used capsaicin cream in an open-label study, there was no significant effect on sensory thresholds after up to 32 wk of use. Although our results and those of others show no adverse effects of topical 0.075% capsaicin on human sensory function, even in subjects with preexisting neuropathic sensory impairment, the small number of subjects tested does not justify an inferential statement on safety. Further studies in more subjects are warranted to ensure the long-term safety of capsaicin for pain relief in humans.